nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00102	0.00102	CcSEcCtD
Cefuroxime—Pruritus—Etidronic acid—osteoporosis	0.00101	0.00101	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Estropipate—osteoporosis	0.00101	0.00101	CcSEcCtD
Cefuroxime—Decreased appetite—Calcitriol—osteoporosis	0.00101	0.00101	CcSEcCtD
Cefuroxime—Erythema—Conjugated Estrogens—osteoporosis	0.001	0.001	CcSEcCtD
Cefuroxime—Muscle spasms—Zoledronate—osteoporosis	0.001	0.001	CcSEcCtD
Cefuroxime—Jaundice—Estradiol—osteoporosis	0.001	0.001	CcSEcCtD
Cefuroxime—Urinary tract infection—Estradiol—osteoporosis	0.001	0.001	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Alendronate—osteoporosis	0.000999	0.000999	CcSEcCtD
Cefuroxime—Cough—Pamidronate—osteoporosis	0.000997	0.000997	CcSEcCtD
Cefuroxime—Pain—Calcitriol—osteoporosis	0.000996	0.000996	CcSEcCtD
Cefuroxime—Flatulence—Conjugated Estrogens—osteoporosis	0.00099	0.00099	CcSEcCtD
Cefuroxime—Convulsion—Pamidronate—osteoporosis	0.00099	0.00099	CcSEcCtD
Cefuroxime—Urticaria—Estropipate—osteoporosis	0.000986	0.000986	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Raloxifene—osteoporosis	0.000983	0.000983	CcSEcCtD
Cefuroxime—Diarrhoea—Etidronic acid—osteoporosis	0.000981	0.000981	CcSEcCtD
Cefuroxime—Abdominal pain—Estropipate—osteoporosis	0.000981	0.000981	CcSEcCtD
Cefuroxime—Body temperature increased—Estropipate—osteoporosis	0.000981	0.000981	CcSEcCtD
Cefuroxime—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000977	0.000977	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Estradiol—osteoporosis	0.000973	0.000973	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Ibandronate—osteoporosis	0.000973	0.000973	CcSEcCtD
Cefuroxime—Arthralgia—Pamidronate—osteoporosis	0.000972	0.000972	CcSEcCtD
Cefuroxime—Urticaria—Alendronate—osteoporosis	0.000971	0.000971	CcSEcCtD
Cefuroxime—Abdominal pain—Alendronate—osteoporosis	0.000966	0.000966	CcSEcCtD
Cefuroxime—Body temperature increased—Alendronate—osteoporosis	0.000966	0.000966	CcSEcCtD
Cefuroxime—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000966	0.000966	CcSEcCtD
Cefuroxime—Sinusitis—Estradiol—osteoporosis	0.000965	0.000965	CcSEcCtD
Cefuroxime—Agitation—Zoledronate—osteoporosis	0.000959	0.000959	CcSEcCtD
Cefuroxime—Angioedema—Zoledronate—osteoporosis	0.000953	0.000953	CcSEcCtD
Cefuroxime—Skin disorder—Risedronate—osteoporosis	0.000953	0.000953	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Calcitriol—osteoporosis	0.000953	0.000953	CcSEcCtD
Cefuroxime—Abdominal pain—Raloxifene—osteoporosis	0.00095	0.00095	CcSEcCtD
Cefuroxime—Body temperature increased—Raloxifene—osteoporosis	0.00095	0.00095	CcSEcCtD
Cefuroxime—Urticaria—Ibandronate—osteoporosis	0.000945	0.000945	CcSEcCtD
Cefuroxime—Abdominal pain—Ibandronate—osteoporosis	0.000941	0.000941	CcSEcCtD
Cefuroxime—Body temperature increased—Ibandronate—osteoporosis	0.000941	0.000941	CcSEcCtD
Cefuroxime—Leukopenia—Zoledronate—osteoporosis	0.000934	0.000934	CcSEcCtD
Cefuroxime—Anaphylactic shock—Pamidronate—osteoporosis	0.000932	0.000932	CcSEcCtD
Cefuroxime—Haemoglobin—Estradiol—osteoporosis	0.000928	0.000928	CcSEcCtD
Cefuroxime—Urticaria—Calcitriol—osteoporosis	0.000925	0.000925	CcSEcCtD
Cefuroxime—Haemorrhage—Estradiol—osteoporosis	0.000924	0.000924	CcSEcCtD
Cefuroxime—Hepatitis—Estradiol—osteoporosis	0.000924	0.000924	CcSEcCtD
Cefuroxime—Palpitations—Zoledronate—osteoporosis	0.000922	0.000922	CcSEcCtD
Cefuroxime—Body temperature increased—Calcitriol—osteoporosis	0.000921	0.000921	CcSEcCtD
Cefuroxime—Abdominal pain—Calcitriol—osteoporosis	0.000921	0.000921	CcSEcCtD
Cefuroxime—Angioedema—Conjugated Estrogens—osteoporosis	0.000918	0.000918	CcSEcCtD
Cefuroxime—Hypersensitivity—Estropipate—osteoporosis	0.000914	0.000914	CcSEcCtD
Cefuroxime—Thrombocytopenia—Pamidronate—osteoporosis	0.000913	0.000913	CcSEcCtD
Cefuroxime—Urinary tract disorder—Estradiol—osteoporosis	0.000912	0.000912	CcSEcCtD
Cefuroxime—Vomiting—Etidronic acid—osteoporosis	0.000912	0.000912	CcSEcCtD
Cefuroxime—Cough—Zoledronate—osteoporosis	0.00091	0.00091	CcSEcCtD
Cefuroxime—Tachycardia—Pamidronate—osteoporosis	0.00091	0.00091	CcSEcCtD
Cefuroxime—Urethral disorder—Estradiol—osteoporosis	0.000905	0.000905	CcSEcCtD
Cefuroxime—Rash—Etidronic acid—osteoporosis	0.000904	0.000904	CcSEcCtD
Cefuroxime—Convulsion—Zoledronate—osteoporosis	0.000904	0.000904	CcSEcCtD
Cefuroxime—Dermatitis—Etidronic acid—osteoporosis	0.000904	0.000904	CcSEcCtD
Cefuroxime—Hyperhidrosis—Pamidronate—osteoporosis	0.000901	0.000901	CcSEcCtD
Cefuroxime—Hypersensitivity—Alendronate—osteoporosis	0.0009	0.0009	CcSEcCtD
Cefuroxime—Headache—Etidronic acid—osteoporosis	0.000899	0.000899	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000893	0.000893	CcSEcCtD
Cefuroxime—Anorexia—Pamidronate—osteoporosis	0.000889	0.000889	CcSEcCtD
Cefuroxime—Chest pain—Zoledronate—osteoporosis	0.000888	0.000888	CcSEcCtD
Cefuroxime—Arthralgia—Zoledronate—osteoporosis	0.000888	0.000888	CcSEcCtD
Cefuroxime—Palpitations—Conjugated Estrogens—osteoporosis	0.000888	0.000888	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000882	0.000882	CcSEcCtD
Cefuroxime—Pruritus—Estropipate—osteoporosis	0.000878	0.000878	CcSEcCtD
Cefuroxime—Hypersensitivity—Ibandronate—osteoporosis	0.000877	0.000877	CcSEcCtD
Cefuroxime—Cough—Conjugated Estrogens—osteoporosis	0.000877	0.000877	CcSEcCtD
Cefuroxime—Dyspnoea—Risedronate—osteoporosis	0.000874	0.000874	CcSEcCtD
Cefuroxime—Erythema multiforme—Estradiol—osteoporosis	0.000873	0.000873	CcSEcCtD
Cefuroxime—Convulsion—Conjugated Estrogens—osteoporosis	0.00087	0.00087	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000868	0.000868	CcSEcCtD
Cefuroxime—Pruritus—Alendronate—osteoporosis	0.000865	0.000865	CcSEcCtD
Cefuroxime—Dyspepsia—Risedronate—osteoporosis	0.000863	0.000863	CcSEcCtD
Cefuroxime—Hypersensitivity—Calcitriol—osteoporosis	0.000858	0.000858	CcSEcCtD
Cefuroxime—Chest pain—Conjugated Estrogens—osteoporosis	0.000855	0.000855	CcSEcCtD
Cefuroxime—Arthralgia—Conjugated Estrogens—osteoporosis	0.000855	0.000855	CcSEcCtD
Cefuroxime—Nausea—Etidronic acid—osteoporosis	0.000852	0.000852	CcSEcCtD
Cefuroxime—Anaphylactic shock—Zoledronate—osteoporosis	0.000852	0.000852	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000849	0.000849	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000849	0.000849	CcSEcCtD
Cefuroxime—Diarrhoea—Estropipate—osteoporosis	0.000849	0.000849	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Risedronate—osteoporosis	0.000847	0.000847	CcSEcCtD
Cefuroxime—Pruritus—Ibandronate—osteoporosis	0.000842	0.000842	CcSEcCtD
Cefuroxime—Pain—Risedronate—osteoporosis	0.000839	0.000839	CcSEcCtD
Cefuroxime—Angiopathy—Estradiol—osteoporosis	0.000838	0.000838	CcSEcCtD
Cefuroxime—Diarrhoea—Alendronate—osteoporosis	0.000836	0.000836	CcSEcCtD
Cefuroxime—Immune system disorder—Estradiol—osteoporosis	0.000834	0.000834	CcSEcCtD
Cefuroxime—Thrombocytopenia—Zoledronate—osteoporosis	0.000834	0.000834	CcSEcCtD
Cefuroxime—Dyspnoea—Pamidronate—osteoporosis	0.000831	0.000831	CcSEcCtD
Cefuroxime—Tachycardia—Zoledronate—osteoporosis	0.000831	0.000831	CcSEcCtD
Cefuroxime—Chills—Estradiol—osteoporosis	0.000829	0.000829	CcSEcCtD
Cefuroxime—Somnolence—Pamidronate—osteoporosis	0.000829	0.000829	CcSEcCtD
Cefuroxime—Skin disorder—Zoledronate—osteoporosis	0.000827	0.000827	CcSEcCtD
Cefuroxime—Pruritus—Calcitriol—osteoporosis	0.000824	0.000824	CcSEcCtD
Cefuroxime—Hyperhidrosis—Zoledronate—osteoporosis	0.000823	0.000823	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000822	0.000822	CcSEcCtD
Cefuroxime—Diarrhoea—Raloxifene—osteoporosis	0.000822	0.000822	CcSEcCtD
Cefuroxime—Dyspepsia—Pamidronate—osteoporosis	0.000821	0.000821	CcSEcCtD
Cefuroxime—Dizziness—Estropipate—osteoporosis	0.000821	0.000821	CcSEcCtD
Cefuroxime—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00082	0.00082	CcSEcCtD
Cefuroxime—Diarrhoea—Ibandronate—osteoporosis	0.000814	0.000814	CcSEcCtD
Cefuroxime—Anorexia—Zoledronate—osteoporosis	0.000812	0.000812	CcSEcCtD
Cefuroxime—Decreased appetite—Pamidronate—osteoporosis	0.00081	0.00081	CcSEcCtD
Cefuroxime—Dizziness—Alendronate—osteoporosis	0.000808	0.000808	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000805	0.000805	CcSEcCtD
Cefuroxime—Erythema—Estradiol—osteoporosis	0.000804	0.000804	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Risedronate—osteoporosis	0.000802	0.000802	CcSEcCtD
Cefuroxime—Tachycardia—Conjugated Estrogens—osteoporosis	0.0008	0.0008	CcSEcCtD
Cefuroxime—Urticaria—Ethinyl Estradiol—osteoporosis	0.000799	0.000799	CcSEcCtD
Cefuroxime—Pain—Pamidronate—osteoporosis	0.000797	0.000797	CcSEcCtD
Cefuroxime—Diarrhoea—Calcitriol—osteoporosis	0.000797	0.000797	CcSEcCtD
Cefuroxime—Skin disorder—Conjugated Estrogens—osteoporosis	0.000796	0.000796	CcSEcCtD
Cefuroxime—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000795	0.000795	CcSEcCtD
Cefuroxime—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000795	0.000795	CcSEcCtD
Cefuroxime—Dizziness—Raloxifene—osteoporosis	0.000795	0.000795	CcSEcCtD
Cefuroxime—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000793	0.000793	CcSEcCtD
Cefuroxime—Flatulence—Estradiol—osteoporosis	0.000792	0.000792	CcSEcCtD
Cefuroxime—Vomiting—Estropipate—osteoporosis	0.000789	0.000789	CcSEcCtD
Cefuroxime—Dizziness—Ibandronate—osteoporosis	0.000787	0.000787	CcSEcCtD
Cefuroxime—Rash—Estropipate—osteoporosis	0.000782	0.000782	CcSEcCtD
Cefuroxime—Dermatitis—Estropipate—osteoporosis	0.000782	0.000782	CcSEcCtD
Cefuroxime—Anorexia—Conjugated Estrogens—osteoporosis	0.000782	0.000782	CcSEcCtD
Cefuroxime—Urticaria—Risedronate—osteoporosis	0.000779	0.000779	CcSEcCtD
Cefuroxime—Headache—Estropipate—osteoporosis	0.000777	0.000777	CcSEcCtD
Cefuroxime—Vomiting—Alendronate—osteoporosis	0.000777	0.000777	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000776	0.000776	CcSEcCtD
Cefuroxime—Abdominal pain—Risedronate—osteoporosis	0.000775	0.000775	CcSEcCtD
Cefuroxime—Body temperature increased—Risedronate—osteoporosis	0.000775	0.000775	CcSEcCtD
Cefuroxime—Muscle spasms—Estradiol—osteoporosis	0.000773	0.000773	CcSEcCtD
Cefuroxime—Rash—Alendronate—osteoporosis	0.000771	0.000771	CcSEcCtD
Cefuroxime—Dermatitis—Alendronate—osteoporosis	0.00077	0.00077	CcSEcCtD
Cefuroxime—Headache—Alendronate—osteoporosis	0.000766	0.000766	CcSEcCtD
Cefuroxime—Vomiting—Raloxifene—osteoporosis	0.000764	0.000764	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Pamidronate—osteoporosis	0.000762	0.000762	CcSEcCtD
Cefuroxime—Dyspnoea—Zoledronate—osteoporosis	0.000759	0.000759	CcSEcCtD
Cefuroxime—Rash—Raloxifene—osteoporosis	0.000758	0.000758	CcSEcCtD
Cefuroxime—Dermatitis—Raloxifene—osteoporosis	0.000757	0.000757	CcSEcCtD
Cefuroxime—Somnolence—Zoledronate—osteoporosis	0.000757	0.000757	CcSEcCtD
Cefuroxime—Vomiting—Ibandronate—osteoporosis	0.000757	0.000757	CcSEcCtD
Cefuroxime—Headache—Raloxifene—osteoporosis	0.000753	0.000753	CcSEcCtD
Cefuroxime—Rash—Ibandronate—osteoporosis	0.00075	0.00075	CcSEcCtD
Cefuroxime—Dermatitis—Ibandronate—osteoporosis	0.00075	0.00075	CcSEcCtD
Cefuroxime—Dyspepsia—Zoledronate—osteoporosis	0.00075	0.00075	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000747	0.000747	CcSEcCtD
Cefuroxime—Headache—Ibandronate—osteoporosis	0.000745	0.000745	CcSEcCtD
Cefuroxime—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000741	0.000741	CcSEcCtD
Cefuroxime—Vomiting—Calcitriol—osteoporosis	0.000741	0.000741	CcSEcCtD
Cefuroxime—Decreased appetite—Zoledronate—osteoporosis	0.00074	0.00074	CcSEcCtD
Cefuroxime—Agitation—Estradiol—osteoporosis	0.000739	0.000739	CcSEcCtD
Cefuroxime—Nausea—Estropipate—osteoporosis	0.000737	0.000737	CcSEcCtD
Cefuroxime—Abdominal pain—Pamidronate—osteoporosis	0.000737	0.000737	CcSEcCtD
Cefuroxime—Body temperature increased—Pamidronate—osteoporosis	0.000737	0.000737	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000735	0.000735	CcSEcCtD
Cefuroxime—Angioedema—Estradiol—osteoporosis	0.000735	0.000735	CcSEcCtD
Cefuroxime—Rash—Calcitriol—osteoporosis	0.000734	0.000734	CcSEcCtD
Cefuroxime—Dermatitis—Calcitriol—osteoporosis	0.000734	0.000734	CcSEcCtD
Cefuroxime—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000731	0.000731	CcSEcCtD
Cefuroxime—Headache—Calcitriol—osteoporosis	0.00073	0.00073	CcSEcCtD
Cefuroxime—Somnolence—Conjugated Estrogens—osteoporosis	0.000729	0.000729	CcSEcCtD
Cefuroxime—Pain—Zoledronate—osteoporosis	0.000728	0.000728	CcSEcCtD
Cefuroxime—Nausea—Alendronate—osteoporosis	0.000726	0.000726	CcSEcCtD
Cefuroxime—Hypersensitivity—Risedronate—osteoporosis	0.000723	0.000723	CcSEcCtD
Cefuroxime—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000722	0.000722	CcSEcCtD
Cefuroxime—Nausea—Raloxifene—osteoporosis	0.000714	0.000714	CcSEcCtD
Cefuroxime—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000713	0.000713	CcSEcCtD
Cefuroxime—Pruritus—Ethinyl Estradiol—osteoporosis	0.000712	0.000712	CcSEcCtD
Cefuroxime—Palpitations—Estradiol—osteoporosis	0.000711	0.000711	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000708	0.000708	CcSEcCtD
Cefuroxime—Nausea—Ibandronate—osteoporosis	0.000707	0.000707	CcSEcCtD
Cefuroxime—Cough—Estradiol—osteoporosis	0.000702	0.000702	CcSEcCtD
Cefuroxime—Pain—Conjugated Estrogens—osteoporosis	0.000701	0.000701	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Zoledronate—osteoporosis	0.000696	0.000696	CcSEcCtD
Cefuroxime—Pruritus—Risedronate—osteoporosis	0.000694	0.000694	CcSEcCtD
Cefuroxime—Nausea—Calcitriol—osteoporosis	0.000692	0.000692	CcSEcCtD
Cefuroxime—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000688	0.000688	CcSEcCtD
Cefuroxime—Hypersensitivity—Pamidronate—osteoporosis	0.000687	0.000687	CcSEcCtD
Cefuroxime—Arthralgia—Estradiol—osteoporosis	0.000685	0.000685	CcSEcCtD
Cefuroxime—Chest pain—Estradiol—osteoporosis	0.000685	0.000685	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00068	0.00068	CcSEcCtD
Cefuroxime—Urticaria—Zoledronate—osteoporosis	0.000676	0.000676	CcSEcCtD
Cefuroxime—Abdominal pain—Zoledronate—osteoporosis	0.000673	0.000673	CcSEcCtD
Cefuroxime—Body temperature increased—Zoledronate—osteoporosis	0.000673	0.000673	CcSEcCtD
Cefuroxime—Diarrhoea—Risedronate—osteoporosis	0.000671	0.000671	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00067	0.00067	CcSEcCtD
Cefuroxime—Dizziness—Ethinyl Estradiol—osteoporosis	0.000665	0.000665	CcSEcCtD
Cefuroxime—Pruritus—Pamidronate—osteoporosis	0.00066	0.00066	CcSEcCtD
Cefuroxime—Anaphylactic shock—Estradiol—osteoporosis	0.000656	0.000656	CcSEcCtD
Cefuroxime—Urticaria—Conjugated Estrogens—osteoporosis	0.000651	0.000651	CcSEcCtD
Cefuroxime—Dizziness—Risedronate—osteoporosis	0.000648	0.000648	CcSEcCtD
Cefuroxime—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000648	0.000648	CcSEcCtD
Cefuroxime—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000648	0.000648	CcSEcCtD
Cefuroxime—Tachycardia—Estradiol—osteoporosis	0.00064	0.00064	CcSEcCtD
Cefuroxime—Vomiting—Ethinyl Estradiol—osteoporosis	0.00064	0.00064	CcSEcCtD
Cefuroxime—Diarrhoea—Pamidronate—osteoporosis	0.000638	0.000638	CcSEcCtD
Cefuroxime—Skin disorder—Estradiol—osteoporosis	0.000637	0.000637	CcSEcCtD
Cefuroxime—Hyperhidrosis—Estradiol—osteoporosis	0.000634	0.000634	CcSEcCtD
Cefuroxime—Rash—Ethinyl Estradiol—osteoporosis	0.000634	0.000634	CcSEcCtD
Cefuroxime—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000634	0.000634	CcSEcCtD
Cefuroxime—Headache—Ethinyl Estradiol—osteoporosis	0.00063	0.00063	CcSEcCtD
Cefuroxime—Hypersensitivity—Zoledronate—osteoporosis	0.000627	0.000627	CcSEcCtD
Cefuroxime—Vomiting—Risedronate—osteoporosis	0.000624	0.000624	CcSEcCtD
Cefuroxime—Rash—Risedronate—osteoporosis	0.000618	0.000618	CcSEcCtD
Cefuroxime—Dermatitis—Risedronate—osteoporosis	0.000618	0.000618	CcSEcCtD
Cefuroxime—Dizziness—Pamidronate—osteoporosis	0.000616	0.000616	CcSEcCtD
Cefuroxime—Headache—Risedronate—osteoporosis	0.000614	0.000614	CcSEcCtD
Cefuroxime—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000604	0.000604	CcSEcCtD
Cefuroxime—Pruritus—Zoledronate—osteoporosis	0.000602	0.000602	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000598	0.000598	CcSEcCtD
Cefuroxime—Nausea—Ethinyl Estradiol—osteoporosis	0.000597	0.000597	CcSEcCtD
Cefuroxime—Vomiting—Pamidronate—osteoporosis	0.000593	0.000593	CcSEcCtD
Cefuroxime—Rash—Pamidronate—osteoporosis	0.000588	0.000588	CcSEcCtD
Cefuroxime—Dermatitis—Pamidronate—osteoporosis	0.000587	0.000587	CcSEcCtD
Cefuroxime—Dyspnoea—Estradiol—osteoporosis	0.000585	0.000585	CcSEcCtD
Cefuroxime—Headache—Pamidronate—osteoporosis	0.000584	0.000584	CcSEcCtD
Cefuroxime—Somnolence—Estradiol—osteoporosis	0.000583	0.000583	CcSEcCtD
Cefuroxime—Diarrhoea—Zoledronate—osteoporosis	0.000583	0.000583	CcSEcCtD
Cefuroxime—Nausea—Risedronate—osteoporosis	0.000582	0.000582	CcSEcCtD
Cefuroxime—Pruritus—Conjugated Estrogens—osteoporosis	0.00058	0.00058	CcSEcCtD
Cefuroxime—Dyspepsia—Estradiol—osteoporosis	0.000578	0.000578	CcSEcCtD
Cefuroxime—Decreased appetite—Estradiol—osteoporosis	0.00057	0.00057	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Estradiol—osteoporosis	0.000567	0.000567	CcSEcCtD
Cefuroxime—Dizziness—Zoledronate—osteoporosis	0.000563	0.000563	CcSEcCtD
Cefuroxime—Pain—Estradiol—osteoporosis	0.000561	0.000561	CcSEcCtD
Cefuroxime—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000561	0.000561	CcSEcCtD
Cefuroxime—Nausea—Pamidronate—osteoporosis	0.000554	0.000554	CcSEcCtD
Cefuroxime—Dizziness—Conjugated Estrogens—osteoporosis	0.000542	0.000542	CcSEcCtD
Cefuroxime—Vomiting—Zoledronate—osteoporosis	0.000541	0.000541	CcSEcCtD
Cefuroxime—Rash—Zoledronate—osteoporosis	0.000537	0.000537	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Estradiol—osteoporosis	0.000537	0.000537	CcSEcCtD
Cefuroxime—Dermatitis—Zoledronate—osteoporosis	0.000536	0.000536	CcSEcCtD
Cefuroxime—Headache—Zoledronate—osteoporosis	0.000533	0.000533	CcSEcCtD
Cefuroxime—Vomiting—Conjugated Estrogens—osteoporosis	0.000521	0.000521	CcSEcCtD
Cefuroxime—Urticaria—Estradiol—osteoporosis	0.000521	0.000521	CcSEcCtD
Cefuroxime—Body temperature increased—Estradiol—osteoporosis	0.000519	0.000519	CcSEcCtD
Cefuroxime—Abdominal pain—Estradiol—osteoporosis	0.000519	0.000519	CcSEcCtD
Cefuroxime—Rash—Conjugated Estrogens—osteoporosis	0.000517	0.000517	CcSEcCtD
Cefuroxime—Dermatitis—Conjugated Estrogens—osteoporosis	0.000516	0.000516	CcSEcCtD
Cefuroxime—Headache—Conjugated Estrogens—osteoporosis	0.000514	0.000514	CcSEcCtD
Cefuroxime—Nausea—Zoledronate—osteoporosis	0.000506	0.000506	CcSEcCtD
Cefuroxime—Nausea—Conjugated Estrogens—osteoporosis	0.000487	0.000487	CcSEcCtD
Cefuroxime—Hypersensitivity—Estradiol—osteoporosis	0.000483	0.000483	CcSEcCtD
Cefuroxime—Pruritus—Estradiol—osteoporosis	0.000464	0.000464	CcSEcCtD
Cefuroxime—Diarrhoea—Estradiol—osteoporosis	0.000449	0.000449	CcSEcCtD
Cefuroxime—Dizziness—Estradiol—osteoporosis	0.000434	0.000434	CcSEcCtD
Cefuroxime—Vomiting—Estradiol—osteoporosis	0.000417	0.000417	CcSEcCtD
Cefuroxime—Rash—Estradiol—osteoporosis	0.000414	0.000414	CcSEcCtD
Cefuroxime—Dermatitis—Estradiol—osteoporosis	0.000413	0.000413	CcSEcCtD
Cefuroxime—Headache—Estradiol—osteoporosis	0.000411	0.000411	CcSEcCtD
Cefuroxime—Nausea—Estradiol—osteoporosis	0.00039	0.00039	CcSEcCtD
